✦ LIBER ✦

PP-117 Thymosin alpha-1 therapy in Chinese patients with chronic hepatitis B: results from a randomized controlled clinical trial

✍ Scribed by Lin Zhuang; Jing You; Hong-Ying Chen; Bao-Zhang Tang; Meng-Ling Huang; Yong-Liang Ma; Jun-Hua Huang; Rong-Xue Wu

Book ID: 118617228
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 56 KB
Volume: 13
Category: Article
ISSN: 1201-9712
DOI: 10.1016/s1201-9712(09)60511-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Randomized, Controlled, Clinical Study

A Randomized, Controlled, Clinical Study of Thymosin Alpha-1 Versus Interferon-Alpha in Chinese Patients with Chronic Hepatitis B Lacking Hepatitis B Envelope Antigen

✍ Jing You; Hong-Ying Cheng; Shou-Ming Yan; Yan-Wei Qiao; Jun-Hua Huang; Bao-Zhang 📂 Article 📅 2005 🏛 Elsevier Science 🌐 Chinese ⚖ 123 KB

The efficacy and safety of thymosin alph

The efficacy and safety of thymosin alpha-1 in Japanese patients with chronic hepatitis B; results from a randomized clinical trial

✍ S. Iino; J. Toyota; H. Kumada; K. Kiyosawa; S. Kakumu; M. Sata; H. Suzuki; E. B. 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB

Efficacy of thymosin α1 in patients with

Efficacy of thymosin α1 in patients with chronic hepatitis B: A randomized, controlled trial

✍ Rong-Nan Chien; Yun-Fan Liaw; Tse-Ching Chen; Chau-Ting Yeh; I.-Shyan Sheen 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB 👁 1 views

Thymosin ␣ 1 (T␣) is an immune modifier that has been shown in a pilot study to be effective for chronic hepatitis B; this requires confirmation. Ninety-eight patients with clinicopathologically proven chronic hepatitis B were randomly allocated to 3 groups: 1) group A received a 26-week course of T

A randomized controlled trial of thymosi

A randomized controlled trial of thymosin-alpha1 versus interferon alfa treatment in patients with hepatitis B e antigen antibody-and hepatitis B virus DNA-positive chronic hepatitis B

✍ P Andreone; C Cursaro; A Gramenzi; C Zavaglia; I Rezakovic; E Altomare; R Severi 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 190 KB

A Randomized, Controlled Study of Thymos

A Randomized, Controlled Study of Thymosin-α1 Therapy in Patients with Anti-HBe, HBV-DNA-Positive Chronic Hepatitis B

✍ Claudio Zavaglia; Remo Severini; Carmine Tinelli; Josè S. Franzone; Aldo Airoldi 📂 Article 📅 2000 🏛 Springer US 🌐 English ⚖ 69 KB

A randomized controlled trial of thymosi

A randomized controlled trial of thymosin-α1 versus interferon alfa treatment in patients with hepatitis B e antigen antibody—and hepatitis B virus DNA—positive chronic hepatitis B

✍ P Andreone; C Cursaro; A Gramenzi; C Zavaglia; I Rezakovic; E Altomare; R Severi 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB 👁 1 views

ment for anti-HBe-positive chronic hepatitis. The benefit It has recently been shown that thymosin-a 1 (T-a 1 ), a of this agent in producing long-term inhibition of HBV synthetic polypeptide of thymic origin, is able to proreplication must be confirmed by future trials. (HEPAmote disease remission